Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

COV.V Relative to the S&P 500

COV.V Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Covalon Technologies Ltd. (TSXV:COV.V) seasonal charts above shows that a Buy Date of March 26 and a Sell Date of June 17 has resulted in a geometric average return of 15.93% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 26.26% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops?wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.

To download COV.V seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: COV.V